Metric Finance
LearnFAQ
LearnFAQ

Learn / DBVT

NASDAQ: DBVT

DBV Technologies S.A. (DBVT) stock, explained like you're 5

DBV Technologies S.A. trades on the Nasdaq under the ticker DBVT. It is a small cap company in the biological products (no diagnostic substances) industry, part of the healthcare sector, with a market value of about 580 million dollars.

Ticker
DBVT
Exchange
Nasdaq
Sector
Healthcare
Industry
Biological Products (No Diagnostic Substances)
Size
Small cap, about 580 million dollars

Is DBV Technologies S.A. a small, medium or large cap company?

No. DBV Technologies S.A. is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 580 million dollars.

Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.

How DBV Technologies S.A. makes money

  • Selling medicines, medical devices or healthcare services.
  • Insurance premiums or hospital and clinic fees.
  • Research and licensing deals.

What moves DBVT stock

  • Results from clinical trials and approvals from regulators.
  • Drug prices, insurance rules and government policy.
  • Patents running out and new competing treatments.

In the news lately

  • DBV Technologies SA (DBV.HA) Stock Price, News, Quote & History (Yahoo! Finance Canada)
  • DBV Technologies SA (CEUX:DBVp) Stock Price, Trades & News (GuruFocus)
  • DBV Technologies SA (DBV.HA) stock price, news, quote and history (Yahoo Finance UK)
  • DBV Technologies: Regulatory Noise, Commercial Misperception, And A Deep Valuation Gap (Seeking Alpha)
  • DBV Technologies (DBVT) Short Interest & Short Float | Updated Oct 2026 (MarketBeat)

Follow DBVT in your daily brief

Each trading day at 5 PM ET we post what happened to DBV Technologies S.A. and why it matters, in simple words. Free.

Start my free brief

Key terms to know before you follow DBVT

  • Market cap
  • P/E ratio
  • EPS (earnings per share)
  • Earnings report
  • Volatility

Questions about DBV Technologies S.A. stock

What does DBV Technologies S.A. do?

DBV Technologies S.A. trades on the Nasdaq under the ticker DBVT. It is a small cap company in the biological products (no diagnostic substances) industry, part of the healthcare sector, with a market value of about 580 million dollars.

What is the ticker symbol for DBV Technologies S.A.?

DBV Technologies S.A. trades under the ticker DBVT on the Nasdaq.

What is DBV Technologies S.A.'s market cap?

DBV Technologies S.A. is a small cap stock with a market cap of about 580 million dollars.

How does DBV Technologies S.A. make money?

Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.

What moves DBVT stock?

Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.

How can I follow DBVT stock every day?

Add DBVT to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.

Follow DBVT daily

A free brief on DBV Technologies S.A. and your other stocks, every trading day at 5 PM ET.

Start my free brief

Similar stocks

  • ARGX · Argenx SE
  • RVMD · Revolution Medicines
  • BNTX · BioNTech SE
  • EXEL · Exelixis

Similar stocks

  • ARGXArgenx SE
  • RVMDRevolution Medicines
  • BNTXBioNTech SE
  • EXELExelixis

Compare DBVT: DBVT vs ARGX, DBVT vs RVMD, DBVT vs BNTX

Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.

Metric Finance

Stocks explained like you're 5.

Product

  • Learn
  • FAQ
  • Your account

Legal

  • Privacy
  • Terms

Support

  • Contact
  • Unsubscribe

© 2026 Metric Finance

Built by Yashna & Vansh · Not investment advice · Market data may be delayed